5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins

British Journal of Cancer

Volumn 78, Issue 8, 1998, Pages 986-992

  Nita, M Eidi ^a   Nagawa, H ^a,b   Tominaga, O ^a   Tsuno, N ^a   Fujii, S ^a   Sasaki, S ^a   Fu, C G ^a   Takenoue, T ^a   Tsuruo, T ^a   Muto, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

5 fluorouracil; Bak; Bax; Bcl X(L); Chemosensitivity; Colon cancer

Indexed keywords

ANTIINFECTIVE AGENT; FLUOROURACIL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRUCTURE; CHEMOSENSITIVITY; COLON CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0343691447     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.617     Document Type: Article

References (37)

1. Aschele C, Sobrero A, Faderan MA and Bertino JR (1992) Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Cancer Res 52: 1855-1864
2. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JK, Hamilton S and Vogelstein B (1990) p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50: 7717-7722
3. Beck A, Etienne MC, Cheradame S, Fischel JL, Formento P, Renee N and Milano G (1994) A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil [see comments]. Eur J Cancer 30A: 1517-1522
4. Bosanquet AG (1989) Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents. Cancer Chemother Pharmacol 23: 197-207
5. Bracey TS, Miller JC, Preece A and Paraskeva C (1995) Gamma-radiation-induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild type p53. Oncogene 10: 2391-2396
6. Canman CE, Tang HY, Normolle DP, Lawrence TS and Maybaum J (1992) Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity. Proc Natl Acad Sci USA 89: 10474-10478
7. Dive C and Hickman JA (1991) Drug-target interactions: only the first step in the commitment to a programmed cell death? Br J Cancer 64: 192-196
8. Dole MG, Jasty R, Cooper MJ, Thompson CB, Nunez G and Castle VP (1995) Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 55: 2576-2582
9. Dou QP, An B and Will PL (1995) Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc Natl Acad Sci USA 92: 9019-9023
10. Enoch T and Norbury C (1995) Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem Sci 20: 426-430
11. Fisher TC, Milner AL, Gregory CD, Jackman AL, Aherne GW, Hartley JA, Dive C and Hickman JA (1993) bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 53: 3321-3326
12. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J and Rickinson AB (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349: 612-614
13. Guillouf C, Grana X, Selvakumaran M, De Luca A, Giordano A, Hoffman B and Liebermann DA (1995) Dissection of the genetic programs of p53-mediated GI growth arrest and apoptosis: blocking p53-induced apoptosis unmasks GI arrest. Blood 85: 2691-2698
14. Gyllensten UB and Erlich HA (1988) Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci USA 85: 7652-7656
15. Harris CC (1996) Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442-1455
16. Huang DC, Cory S and Strasser A (1997) Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14: 405-414
17. Inaba M, Mitsuhashi J and Ozawa S (1990) Kinetic analysis of 5-fluorouracil action against various cancer cells. Jpn J Cancer Res 81: 1039-1044
18. Kerr JF, Winterford CM and Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy [published erratum appears in Cancer (1994) Jun 15; 73(12): 3108]. Cancer 73: 2013-2026
19. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR and Reed JC (1996) Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 56: 2422-2427
20. Kuhl JS, Krajewski S, Duran GE, Reed JC and Sikic BI (1997) Spontaneous overexpression of the long form of the Bcl-X protein in a highly resistant P388 leukaemia. Br J Cancer 75: 268-274
21. Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR, Gerwin BI and Harris CC (1991) p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 51: 4090-4096
22. Lowe SW, Ruley HE, Jacks T and Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967
23. Merchant AK, Loney TL and Maybaum J (1996) Expression of wild-type p53 stimulates an increase in both Bax and Bcl-xL protein content in HT29 cells. Oncogene 13: 2631-2637
24. Miyashita T and Reed JC (1992) bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res 52: 5407-5411
25. Miyashita T and Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81: 151-157
26. Nabeya Y, Loganzo Jr F, Maslak P, Lai L, de Oliveira AR, Schwartz GK, Blundell ML, Altorki NK, Kelsen DP and Albino AP (1995) The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. Int J Cancer 64: 37-46
27. Oltvai ZN and Korsmeyer SJ (1994) Checkpoints of dueling dimers foil death wishes [comment]. Cell 79: 189-192
28. Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC and Zunino F (1996) Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res 56: 556-562
29. Piazza GA, Rahm, AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukeu R and Ahnen DJ (1997) Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res 57: 2452-2459
30. Polyak K, Waldman T, He TC, Kinzler KW and Vogelstein B (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10: 1945-1952
31. Reeve JG, Xiong J, Morgan J and Bleehen NM (1996) Expression of apoptosis-regulatory genes in lung tumour cell lines: relationship to p53 expression and relevance to acquired drug resistance. Br J Cancer 73: 1193-1200
32. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV and Lane DP (1990) p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559
33. Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Nakatani H, Tsujimoto H, Imanishi T, Ohgaki M, Ohyama T, Yamazaki J, Hagiwara A, Yamaguchi T, Sawai K and Takahashi T (1996) Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer 67: 101-105
34. Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB and Korsmeyer SJ (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 92: 7834-7838
35. Strobel T, Swanson L, Korsmeyer S and Cannistra SA (1996) BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci USA 93: 14094-14099
36. Tominaga O, Nita ME, Nagawa H, Fujii S, Tsuruo T and Muto T (1997) Expression of cell cycle regulators in human colorectal cancer cell lines. Jpn J Cancer Res 88: 855-860
37. Yang E and Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88: 386-401